About MagGenome
MagGenome is a Healthcare company based in Kochi (India) founded in 2014 by Sam Santhosh and Sreedhar Santhosh. Nucleic acid extraction kits are developed using nanoparticle technology. MagGenome has raised $1.11 million across 4 funding rounds from investors including S Arumugam, Emerge Ventures and SCI Ventures. The company has 30 employees. MagGenome was last valued at $3.13 million in March 2020. Its Indian entity Maggenome Technologies Private Limited reported revenue of ₹86.2 Lakh. MagGenome offers products and services including XpressDNA Blood Kit, XpressDNA Saliva Kit, XpressDNA Tissue Kit, XpressPure Beads, and MagStable DNA Saliva Collection Kit. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents.
Company details
MagGenome was founded in 2014 in Kochi, India, within the biotechnology sector. Genomic DNA extraction kits are provided through nanoparticle synthesis technology. Operations include the production of kits such as XpressDNA Blood mini kit and XpressDNA TissueCell line mini kit, along with the affinity resin-based XpressAffinity kit. Emphasis is placed on future diagnostics and therapeutic applications involving nanoparticle technology.
- Headquarters Kochi, India
- Employees 30
- Founders Sam Santhosh, Sreedhar Santhosh
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website maggenome.com
- Social LinkedIn X Facebook YouTube
- Legal Name Maggenome Technologies Private Limited
- Date of Incorporation 25 May, 2015
- Jurisdiction Ernakulam, Kerala, India
- Annual Revenue₹86.2 Lakh
FY 2025 · -6% YoY
- Net Loss-₹2.64 Cr
FY 2025 · -307% margin
- EBITDA-₹2.38 Cr
FY 2025 · -277% margin
- Total Equity Funding$1.11M (USD)
in 4 rounds
- Latest Funding Round$175.58K (USD), Angel Round
Mar 2020
- InvestorsEmerge Ventures
& 2 more
- Employee Count30
Associated legal entities of MagGenome
MagGenome operates through Maggenome Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Maggenome Technologies Private Limited CIN U74999KL2015PTC038529 | Active | 25 May 2015 | Ernakulam, Kerala | ₹0.9 Cr | 30 | 3 | View details |
Products & Services of MagGenome
MagGenome offers a comprehensive portfolio of products and services, including XpressDNA Blood Kit, XpressDNA Saliva Kit, XpressDNA Tissue Kit, XpressPure Beads, and MagStable DNA Saliva Collection Kit.
Kit for high-yield DNA extraction from blood samples.
Kit for DNA extraction from saliva for testing.
Kit for DNA extraction from tissue samples.
Beads for removing impurities from PCR reactions.
Kit for collecting and transporting saliva DNA.
Apps and channels of MagGenome
its YouTube channel MagGenome has 69 subscribers and 22 videos.
Videos from MagGenome
The most watched videos on MagGenome's YouTube channel, MagGenome (69 subscribers). Click a video to play it here.
More on MagGenome.
Funding Insights of MagGenome
MagGenome has successfully raised a total of $1.11M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $175.58 thousand completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.11M
- Total Rounds 4
- Last Round Angel Round — $175,575
- First Round $189,772
(Jan 2016)
- Investors Count 3
All 4 funding rounds of MagGenome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $175,575 | Angel Round | $3.13M | S Arumugam | – |
| Feb 2019 | $176,836 | Angel Round | – | S Arumugam | – |
| Feb 2018 | $570,250 | Angel Round | $2.54M | S Arumugam | – |
| Jan 2016 | $189,772 | Seed | $••••• | Emerge Ventures |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2020 | $3.13M | •••••••• |
| Feb 2018 | $2.54M | •••••••• |
Last known valuation $3.13M (Mar 2020). 3 investors in total: 2 institutional and 1 angel.
Investors in MagGenome
MagGenome has secured backing from 3 investors, including angel and venture fund investors. Prominent investors backing the company include S Arumugam, Emerge Ventures and SCI Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth stage tech and life sciences focused VC firm investing primarily in India and the US | emergeout.com | Singapore, Singapore | ||
Investments in women-led US companies are made by SCI Ventures. | sci-ventures.com | Baltimore, United States | ||
SA S Arumugam | unknown_2cc470cd4b694d26b |
Investor details for MagGenome
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Maggenome Technologies Private Limited (MagGenome)
Maggenome Technologies Private Limited is the primary company behind MagGenome. The board of Maggenome Technologies Private Limited currently have 3 directors; the longest-serving is Balamaniamma Madathinkal Raghavan Nair, appointed in 2015. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Balamaniamma Madathinkal Raghavan Nair DIN 02231058 | Director | 25 May 2015 | 11 yrs 5 mo | Maggenome Technologies Private Limited |
| Chaniyilparampu Nanappan Ramchand DIN 05166709 | Director | 15 Jun 2023 | 3 yrs 4 mo | Maggenome Technologies Private Limited |
| Jegatheesan Mohan DIN 10609208 | Director | 20 Aug 2025 | 1 yr 2 mo | Maggenome Technologies Private Limited |
People of MagGenome
4 people are tracked at MagGenome (3 in leadership, 1 in team); the tracked headcount is 30.
| Name | Role | Group |
|---|---|---|
Sam Santhosh | Co-Founder & Chairman | Leadership |
| Co-Founder | Leadership | |
Ramchand CN | CEO | Leadership |
Nirali Kargathara | Techno Commercial Executive | Team |
Complete people profiles for MagGenome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of MagGenome
Figures of Maggenome Technologies Private Limited, the primary company behind MagGenome, for FY 2025. Revenue was ₹86.2 Lakh (-6% year on year). Net loss was -₹2.64 Cr (-307% margin). EBITDA was -₹2.38 Cr (-277% margin). Revenue has grown at a compounded annual rate of -65% over three years and +6% over five years.
- ₹86.2 LakhRevenue · FY 2025 · -6% YoY
- -₹2.64 CrNet loss · -307% margin
- -₹2.38 CrEBITDA · -277% margin
- ₹4.4 LakhPaid-up capital
- 30Employees (provident fund records)
- -65%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Maggenome Technologies Private Limited are on its company page.
Detailed financial statements for MagGenome
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of MagGenome
4 dated milestones of MagGenome across 6 years, from founding to its latest funding, stage changes and deals.
- Founded MagGenome is founded.
- Funding First funding round of $190K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $176K.
Web traffic of MagGenome
The website of MagGenome (maggenome.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▼ 70.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Maggenome
Complete news archive for MagGenome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MagGenome
MagGenome was founded in 2014 and raised its 1st funding round 2 years after it was founded.
MagGenome is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
MagGenome is a funded company, having raised a total of $1.11M across 4 funding rounds to date. The company's 1st funding round was a Seed of $189.77K, raised on Jan 2016.
MagGenome has 30 employees.
The primary company behind MagGenome, Maggenome Technologies Private Limited, reported revenue of ₹86.2 Lakh for FY 2025, down 6% year on year.
MagGenome was founded in 2014 in Kochi, India, within the biotechnology sector. Genomic DNA extraction kits are provided through nanoparticle synthesis technology. Operations include the production of kits such as XpressDNA Blood mini kit and XpressDNA TissueCell line mini kit, along with the affinity resin-based XpressAffinity kit. Emphasis is placed on future diagnostics and therapeutic applications involving nanoparticle technology.
MagGenome offers XpressDNA Blood Kit, XpressDNA Saliva Kit, XpressDNA Tissue Kit, XpressPure Beads, and MagStable DNA Saliva Collection Kit.
MagGenome has 3 investors. Key investors include S Arumugam, Emerge Ventures, and SCI Ventures.
The valuation of MagGenome is $3.13M as of Mar 2020.
MagGenome operates through Maggenome Technologies Private Limited.
The legal entities of MagGenome currently have 3 directors, including Balamaniamma Madathinkal Raghavan Nair, Chaniyilparampu Nanappan Ramchand, Jegatheesan Mohan.